ClinicalTrials.gg
Drug

Rimonabant clinical trials

Also written SR141716.

studies test it
46
open now
2
in phase 3
35
first study started
2001

How each study uses Rimonabant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Rimonabant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
19 Jun 2006 · Acomplia · EMEA/H/C/000666 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rimonabant
29
Rimonabant (SR141716)
16
Acomplia
13

Development codes

SR141716
11

Studies by the year they started

46 studies that test it; most in 2007 (9)

Studies that test Rimonabant, by start year
YearStudies
20014
20023
20031
20045
20056
20067
20079
20086
20211
20221
20263

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
9
Phase 3
35
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 38 · Other 8

Sanofi (35) · Sinfatin S.L (3) · Hospital Nacional de Parapléjicos de Toledo (2) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · The Scripps Research Institute (1) · Aristotle University Of Thessaloniki (1) · Weill Medical College of Cornell University (1) · University of Maryland, Baltimore (1)

Often tested with

Tested in the same studies.

Metformin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Rimonabant.

Studies

Open first, then newest update. How each study uses Rimonabant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 46

See all 46 studies that test Rimonabant →

Given beside what is tested · 1 — Rimonabant is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Rimonabant · ClinicalTrials.gg INT006687

  • MeSH (NLM) D000077285RimonabantConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) RML78EN3XERIMONABANTConfirmed FDA, NLM, Wikidata
  • Wikidata Q412529rimonabantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C73244RimonabantOne source FDA
  • DrugBank DB06155One source Wikidata

Also registered as rimonabant hydrochloride (UNII HL0V2LQZ09).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.